FDA Inspection
Hisamitsu Pharmaceutical Co., Inc.Hisamitsu Pharmaceutical Co., Inc. – FDA Inspection, Feb 17, 2012
Record Details
This FDA Inspection record concerns Hisamitsu Pharmaceutical Co., Inc., with an inspection on February 17, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 17, 2012
- Product Type
- Drugs
View Company Profile
ID · b31fbcb6-c00b-4dfc-aaba-ba837d5066f2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 770008
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
8- 21 CFR 211.58Buildings not maintained in good state of repair
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.110(b)In-process materials specifications
- 21 CFR 211.122(a)Sampling/testing of labeling/packaging materials
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.170(b)Annual visual exams of drug products
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hisamitsu Pharmaceutical Co., Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 4, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
| May 31, 2019 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| September 15, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 11, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 1, 2009 | NAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
Other documents for Hisamitsu Pharmaceutical Co., Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.